Abstract:Background: There is emerging realization of the central role of metabolism in carcinogenesis with the Warburg effect (preferential utilization of glycolysis in normoxic environment) (e.g.Weinberg, Cell 2012).We have previously noted an increase in microvascular blood supply in the predysplastic colonic mucosa (field carcinogenesis) (Gut 2005, Gastro 2008, Clin Cancer Res 2009, Cancer Prev Res 2010) which may reflect altered metabolism, however molecular determinants remain unexplored.The role of mitochondria in CRC is well established in frank tumors with dysfunction reflected by increased fission leading to less efficient oxidative phosphorylation, enabling shunting of precursors for cell growth.However, the presence of mitochondrial dysfunction and Warburg effect in early colon carcinogenesis has yet been explored.Therefore, we chose to investigate potential mitochondrial changes in the pre-malignant colon.Methods: To investigate mitochondrial changes we incorporated both human and animal studies: For human studies we obtained biopsies from endoscopically normal rectal muscosa from 80 patients undergoing screening colonoscopies.Samples were processed for gDNA and RNA isolation.Real Time PCR was conducted to assess mitochondrial mass, OPA-1, UCP2, and PKM2 expression.For animal experiments we utilized the Polypopsis in Rat Colon (Pirc) rat, which possesses an APC truncation, consistent with the initiating factor in ~80% of sporadic CRCs.7 Pirc rats with age-matched controls were euthanized after 24 wks of age.Colons were excised from these animals to obtain colonic gDNA and RNA.Real Time PCR was conducted to assess mitochondrial mass, OPA-1 and UCP2 expression.Results: In patient biopsies, mitochondrial mass was shown to be upregulated with adenomal presence (~72% increase, p=0.05).Pirc rats were also shown to possess a 63.6% induction of mitochondrial mass (p=0.03).OPA-1 expression was upregulated in both patients with adenomas as well as Pirc rats (49%, p=0.05 and 67%, p<0.03 respectively).Induction of UCP2 was detected in patients with adenomas (99%, p<0.04) and in Pircs (101%, p=0.05).Interestingly, patients with lesions had a 80% increase in PKM2 (p=0.002),suggestive of a Warburg effect in early colon carcinogenesis.Conclusions: We demonstrate for the first time, that in the predysplastic mucosa there is profound metabolic alterations consistent with a Warburg effect.Specifically, we noted increased mitochondria mass (fission) which suppresses oxidative phosphorylation.Aside from structural alterations, electron transport system is further inhibited by overexpression of UCP2.Biologically, this provides insight into early metabolic events in colon carcinogenesis.Clinically, these insights may enable novel biomarkers for early detection and also a myriad of potentially "druggable" targets for chemoprevention.

Integrated multi-omic analyses provide insight into colon adenoma susceptibility modulation by the gut microbiota

Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis

Data from Genome-Wide Association and Fine Mapping of Genetic Loci Predisposing to Colon Carcinogenesis in Mice

Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer

Abstract 3051: Commensal microbiota, host DNA methylation and gene expression: A pilot study in colorectal adenomas

Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers

Sa1914 the Genomic Landscape of Human Colon Adenomas Reveals Early Driver Mutations and a TGF-β-CEA Regulated Profile

From colon wall to tumor niche: Unraveling the microbiome's role in colorectal cancer progression

The Colorectal Cancer Microbiota Alter Their Transcriptome To Adapt to the Acidity, Reactive Oxygen Species, and Metabolite Availability of Gut Microenvironments

Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer

Altered Tissue Metabolites Correlate with Microbial Dysbiosis in Colorectal Adenomas

Integrated analysis of the gut microbiome and metabolome in a mouse model of inflammation-induced colorectal tumors

Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis

Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer

Colorectal cancer-associated bacteria are broadly distributed in global microbiomes and drivers of precancerous change

IDDF2021-ABS-0210 Altered Gut Metabolites and Bacterial Interactions Are Implicated in Colorectal Carcinogenesis and Can Detect Precancerous and Cancerous Lesions

Integration of the Microbiome, Metabolome and Transcriptomics Data Identified Novel Metabolic Pathway Regulation in Colorectal Cancer

Gut microbiome development along the colorectal adenoma–carcinoma sequence

Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention

Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer

Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APCMin/+ Mice